Acipimox

Objective To synthesis the acipimox intermediate .

目的合成阿西莫司中间体。

Both drugs increased HDL-ch and Apo AI / Apo B 100 . Bezafibrate group decreased range of TG levels was senior to acipimox group ( P0.05 ) .

2药且均有升高高密度脂蛋白胆固醇、载脂蛋白AI/载脂蛋白B100的作用，苯扎贝特降低TG的水平高于阿西莫司（P0.05）。

Objective To establish the assay method of dissolution rate on Acipimox Capsules .

目的确立阿昔莫司胶囊溶出度测定方法。

Effect of acipimox for treating combined hyperlipidemia in the elderly patients with diabetes

阿昔莫司对老年糖尿病患者混合型高脂血症的影响

Curative Effects and Safety Study of Acipimox Combined with Fluvastatin Treating the Aged with Mixed Hyperlipemia

阿昔莫司联合氟伐他汀治疗老年混合型高脂血症的疗效和安全性研究

Feasibility of ~ ( 18 ) F-FDG myocardial metabolism imaging following oral acipimox in patients with diabetes mellitus

氧甲吡嗪在糖尿病患者~（18）F-FDG心肌代谢显像中的作用